Showing results (1451-1460 of 9,902) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|January 10, 2006
Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trialC Harter, B Schulze, H Goldschmidt, et al.
Bone Marrow Transplantation|January 10, 2006
Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantationY Atsuta, R Suzuki, K Yamamoto, et al.
Bone Marrow Transplantation|January 10, 2006
Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasmsR Suzuki, J Suzumiya, S Nakamura, et al.
Bone Marrow Transplantation|January 26, 2006
A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autograftsH Yang, C Eaves, M de Lima, et al.
Bone Marrow Transplantation|January 26, 2006
Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapseC-K Min, S Y Kim, K S Eom, et al.
Bone Marrow Transplantation|January 26, 2006
Fludarabine phosphate and melphalan: a reduced intensity conditioning regimen suitable for allogeneic transplantation that maintains the graft versus malignancy effectR K Dasgupta, S Rule, P Johnson, et al.
Bone Marrow Transplantation|January 26, 2006
Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myelomaJ I Arango, A Restrepo, D L Schneider, et al.
Bone Marrow Transplantation|January 18, 2006
Increased acute GvHD and higher transplant-related mortality in non-caucasians undergoing standard sibling allogeneic stem cell transplantationM Karanth, G Begum, M Cook, et al.
Bone Marrow Transplantation|January 18, 2006
Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS)N Kröger, A Shimoni, T Zabelina, et al.
Bone Marrow Transplantation|January 18, 2006
Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimenP Frère, F Baron, C Bonnet, et al.
Pageof 991